
Join to view full profile
201 North Broadway StreetViragh BLDG 5th FLBaltimore, MD 21287
Phone+1 410-955-8964
Fax+1 410-367-2194
Dr. Grossman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1979 - 1981
University of Rochester Medical CenterResidency, Internal Medicine, 1973 - 1976
University of Rochester School of Medicine and DentistryClass of 1973
Certifications & Licensure
MD State Medical License 1979 - 2026
VA State Medical License 2023 - 2026
PA State Medical License 2020 - 2022
WI State Medical License 1976 - 1978
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsVolumetric Analysis of Contrast Enhancement in Patients With Newly Diagnosed Glioblastomas.Max A Saint-Germain, Mohamed Sherief, Haris I Sair, Karisa C Schreck, Debraj Mukherjee
Neurosurgery. 2026-09-01 - Evaluating "brain permeability": A critical issue for the development of therapeutic agents for primary and metastatic brain tumors.Stuart A Grossman, Amy Barone, Roy E Strowd, Rana Rais, Elizabeth Duke
Neuro-Oncology. 2026-07-01 - Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.Michael Lim, Xiaobu Ye, Anna F Piotrowski, Arati Desai, Manmeet S Ahluwalia
Nature Medicine. 2026-07-01
Journal Articles
- The Role of Temozolomide in Patients with Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 PandemicStuart Grossman, MD, JAMA Oncology
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/stuart-grossman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









